Form 8-K - Current report:
SEC Accession No. 0001193125-25-132838
Filing Date
2025-06-02
Accepted
2025-06-02 08:30:21
Documents
51
Period of Report
2025-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d943327d8k.htm   iXBRL 8-K 25212
2 EX-99.1 d943327dex991.htm EX-99.1 45049
6 GRAPHIC g943327ex99_1p10g1.jpg GRAPHIC 390092
7 GRAPHIC g943327ex99_1p11g1.jpg GRAPHIC 329081
8 GRAPHIC g943327ex99_1p12g1.jpg GRAPHIC 456984
9 GRAPHIC g943327ex99_1p13g1.jpg GRAPHIC 321822
10 GRAPHIC g943327ex99_1p14g1.jpg GRAPHIC 349859
11 GRAPHIC g943327ex99_1p15g1.jpg GRAPHIC 382053
12 GRAPHIC g943327ex99_1p16g1.jpg GRAPHIC 366879
13 GRAPHIC g943327ex99_1p17g1.jpg GRAPHIC 307514
14 GRAPHIC g943327ex99_1p18g1.jpg GRAPHIC 486961
15 GRAPHIC g943327ex99_1p19g1.jpg GRAPHIC 177501
16 GRAPHIC g943327ex99_1p1g1.jpg GRAPHIC 420387
17 GRAPHIC g943327ex99_1p20g1.jpg GRAPHIC 218174
18 GRAPHIC g943327ex99_1p21g1.jpg GRAPHIC 302559
19 GRAPHIC g943327ex99_1p22g1.jpg GRAPHIC 295215
20 GRAPHIC g943327ex99_1p23g1.jpg GRAPHIC 366659
21 GRAPHIC g943327ex99_1p24g1.jpg GRAPHIC 382005
22 GRAPHIC g943327ex99_1p25g1.jpg GRAPHIC 342895
23 GRAPHIC g943327ex99_1p26g1.jpg GRAPHIC 435983
24 GRAPHIC g943327ex99_1p27g1.jpg GRAPHIC 349448
25 GRAPHIC g943327ex99_1p28g1.jpg GRAPHIC 342764
26 GRAPHIC g943327ex99_1p29g1.jpg GRAPHIC 287928
27 GRAPHIC g943327ex99_1p2g1.jpg GRAPHIC 267910
28 GRAPHIC g943327ex99_1p30g1.jpg GRAPHIC 198798
29 GRAPHIC g943327ex99_1p31g1.jpg GRAPHIC 424050
30 GRAPHIC g943327ex99_1p32g1.jpg GRAPHIC 385738
31 GRAPHIC g943327ex99_1p33g1.jpg GRAPHIC 353347
32 GRAPHIC g943327ex99_1p34g1.jpg GRAPHIC 356348
33 GRAPHIC g943327ex99_1p35g1.jpg GRAPHIC 401782
34 GRAPHIC g943327ex99_1p36g1.jpg GRAPHIC 314240
35 GRAPHIC g943327ex99_1p37g1.jpg GRAPHIC 487042
36 GRAPHIC g943327ex99_1p38g1.jpg GRAPHIC 199513
37 GRAPHIC g943327ex99_1p3g1.jpg GRAPHIC 990059
38 GRAPHIC g943327ex99_1p4g1.jpg GRAPHIC 154967
39 GRAPHIC g943327ex99_1p5g1.jpg GRAPHIC 378454
40 GRAPHIC g943327ex99_1p6g1.jpg GRAPHIC 360274
41 GRAPHIC g943327ex99_1p7g1.jpg GRAPHIC 385156
42 GRAPHIC g943327ex99_1p8g1.jpg GRAPHIC 304610
43 GRAPHIC g943327ex99_1p9g1.jpg GRAPHIC 365154
  Complete submission text file 0001193125-25-132838.txt   18991717

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kymr-20250602.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kymr-20250602_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kymr-20250602_pre.xml EX-101.PRE 11262
53 EXTRACTED XBRL INSTANCE DOCUMENT d943327d8k_htm.xml XML 3646
Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39460 | Film No.: 251013218
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)